Development of an antibody reformatting strategy for use in targeted protein degradation therapies for neurodegenerative diseases

PRODUCTS USED

Genes
Read Full Article

ABSTRACT

Neurodegenerative diseases (NDDs) such as Parkinson’s disease (PD) and amyotrophic lateral sclerosis (ALS) are a leading cause of global mortality and place a great financial and emotional burden on healthcare systems and support networks. Misfolded insoluble aggregates and toxic soluble proteins are central hallmarks of these NDDs. α-Synuclein aggregation drives Parkinson’s disease pathology and is a suitable target for selective protein clearance. Biological proteolysis targeting chimeras (bioPROTACs) aim to eliminate disease-causing intracellular proteins using host cell ubiquitination and degradation pathways. Here, I describe a bioPROTAC comprising the E3 ubiquitin ligase domain of CHIP (carboxy terminus of Hsc70-interacting protein) fused to NbSyn87, a nanobody specific for α-synuclein. Successful target degradation was achieved using the CHIP-NbSyn87 bioPROTAC. In contrast, CHIP-based bioPROTACs targeting SOD1, a ubiquitously expressed protein prone to misfold and aggregate in ALS, failed to degrade its target. This work highlighted key parameters for consideration during BioPROTAC design including target half-life and solubility, recognition domain binding affinity, molecular chaperone activity, and interdomain linker optimisation. A strategy for rational repurposing of conformation-specific antibodies into soluble, functional intrabodies was also developed. Candidate antibodies were reformatted into scFvs and their solubility and specificity tested. A panel of misfolding-specific SOD1 intrabodies and conformation-specific α-synuclein intrabodies are described. Almost any antibody can be reformatted as a highly soluble (>70 %) and intracellularly stable intrabody using the described approach, based on the discovery of a strong negative correlation between net charge and intrabody solubility in cell models.

Read Full Article

PRODUCTS USED

Genes